ICU Medical, Inc. (NASDAQ:ICUI) Short Interest Up 13.5% in July

ICU Medical, Inc. (NASDAQ:ICUI) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 1,510,000 shares, a growth of 13.5% from the June 30th total of 1,330,000 shares. Based on an average daily trading volume, of 297,800 shares, the short-interest ratio is currently 5.1 days. Currently, 6.7% of the company’s stock are sold short.

ICU Medical Stock Performance

NASDAQ:ICUI traded down $1.45 on Monday, hitting $126.58. The company’s stock had a trading volume of 253,183 shares, compared to its average volume of 275,126. ICU Medical has a one year low of $78.28 and a one year high of $179.01. The firm has a market capitalization of $3.08 billion, a P/E ratio of -52.26 and a beta of 0.69. The stock has a fifty day moving average of $115.90 and a two-hundred day moving average of $105.70. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76.

ICU Medical (NASDAQ:ICUI) last posted its earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.06. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. The business had revenue of $566.66 million for the quarter, compared to analyst estimates of $553.15 million. Research analysts predict that ICU Medical will post 3.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on ICUI. Raymond James upgraded shares of ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 price target on the stock in a research note on Monday, June 17th. Needham & Company LLC began coverage on ICU Medical in a research report on Friday, June 21st. They set a “hold” rating on the stock. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and an average target price of $127.00.

Insiders Place Their Bets

In other news, insider Ben Sousa sold 2,000 shares of the stock in a transaction on Friday, May 10th. The shares were sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the sale, the insider now owns 1,319 shares of the company’s stock, valued at $139,220.45. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Ben Sousa sold 2,000 shares of the company’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the completion of the transaction, the insider now directly owns 1,319 shares of the company’s stock, valued at $139,220.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Christian B. Voigtlander sold 12,539 shares of the stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $103.95, for a total value of $1,303,429.05. The disclosure for this sale can be found here. In the last three months, insiders have sold 14,839 shares of company stock worth $1,546,014. Company insiders own 6.70% of the company’s stock.

Hedge Funds Weigh In On ICU Medical

Large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in ICU Medical by 0.5% during the 1st quarter. Vanguard Group Inc. now owns 2,452,720 shares of the medical instruments supplier’s stock worth $263,226,000 after purchasing an additional 11,991 shares during the last quarter. Schroder Investment Management Group increased its position in ICU Medical by 35.8% during the 4th quarter. Schroder Investment Management Group now owns 433,852 shares of the medical instruments supplier’s stock worth $43,272,000 after buying an additional 114,344 shares during the period. Silvercrest Asset Management Group LLC lifted its holdings in shares of ICU Medical by 109.4% during the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock worth $29,882,000 after buying an additional 145,485 shares in the last quarter. WCM Investment Management LLC boosted its position in shares of ICU Medical by 5.8% in the first quarter. WCM Investment Management LLC now owns 256,946 shares of the medical instruments supplier’s stock valued at $27,575,000 after acquiring an additional 14,138 shares during the period. Finally, Dimensional Fund Advisors LP grew its stake in shares of ICU Medical by 4.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 220,624 shares of the medical instruments supplier’s stock valued at $22,005,000 after acquiring an additional 9,196 shares in the last quarter. 96.10% of the stock is owned by institutional investors.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.